The company has recently been awarded the " Manufacture License of Pharmaceutical Products " C certificate issued by NMPA in 2022. The certificate number is "Beijing 20220037".
The license application was submitted and accepted on February 23, 2022, and the on-site inspection was passed on March 10, 2022. The approval date of the certificate is March 15, 2022. The information is available on the official website of Beijing Municipal Medical Products Administration. (website: http://xxcx.yjj.beijing.gov.cn/eportal/ui?pageId=723636).
After careful preparation and planning by all functional departments of the company, it took only 15 working days for the company to acquire this license from the submission of documents, data review, on-site verification to the approval of the certificate. Which reflects not only the software and hardware strength of the company, but also the generous support of the Beijing Government and the Beijing Municipal Medical Products Administration for the biomedical industry in Beijing, especially the biomedical CDMO enterprises.
